Zimmer Striving for Market Growth

Zimmer Holdings currently has exposure of 75 percent for hip and knee orthopedic device markets, and the company is looking to grow., according to the Wall Street Transcript.

Advertisement

The company has been improving manufacturing processes and fixed costs over four years and could expect to see 8 to 10 percent free cash flow yield, according to the report.

Zimmer has also been investing in emerging markets, such as China and India.

More Articles on Supply Chain:
American Spine Expands to Gettysburg
Miami Project to Cure Paralysis Successfully Transplants Human Cells for Spinal Cord Injury
Outlook for Spinal Non-Fusion Technology Trends: Q&A with Joe Ross of LDR

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

  • A Pleasant View, Utah-based physician has been indicted on charges of obtaining unapproved drugs from China and selling them to…

  • From payer obstacles to operational pressures, five ASC leaders discuss the biggest frictions they’re facing. Note: Responses were lightly edited.…

Advertisement

Comments are closed.